Latest Guidance News

Centuria Industrial REIT delivered 4% growth in funds from operations for FY26 and expects another lift in FY27, supported by leasing momentum and embedded rental reversion. The opportunity comes with a more exposed interest-rate profile and a development pipeline that still depends on power, planning and execution.

Prescient Therapeutics has raised approximately $6 million through its Share Purchase Plan and a shortfall placement, giving PTX-100 additional funding beyond a key clinical review in December. The next test is whether early results support a move into Phase 2b development.

Synertec has raised its FY27 revenue guidance by $8.0 million to $8.3 million, pointing to stronger contract conversion and visibility across its Engineering and Powerhouse businesses. The upgrade follows the $45.5 million ANSTO nuclear medicine manufacturing contract, but covers revenue only and not earnings or cash flow.

Ventia has secured an extension of its Western Australia Court Security and Custodial Services contract, expected to generate approximately $110 million in revenue through June 2028. The deal provides additional visibility for a long-running government services relationship, although the announcement does not disclose margins or any change to company guidance.

Tuas Limited (ASX:TUA) delivered a sharp FY2026 earnings lift as Simba’s mobile and broadband subscriber base expanded, with statutory profit rising 277% to S$26.0 million. The result arrives with the M1 acquisition abandoned, S$364.5 million raised but not yet allocated, and an unresolved Singapore spectrum investigation.

Dimensional’s five ASX-quoted trusts all produced positive total returns in the year to 30 June 2026, led by the Global Value Trust at 27.812%. The audited report also records lower management fees for three global strategies, although the figures remain a look back rather than a forecast.

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

Basin Energy has begun preliminary leachability and XRD studies at its Newmans rare earth discovery, with follow-up drilling assays due imminently. The early-stage program adds a recoverability test to a project already showing a 3.3 km mineralised corridor in northwest Queensland.

Gold Corporation, trading as The Perth Mint (ASX:GCB), reported a record $100.19 million profit before tax for 2025-26 and recommended its largest-ever dividend to the Western Australian Government. The result was powered by extraordinary precious-metals demand and prices, but the company’s own budget points to a much leaner year ahead.

Harmoney will continue buying back up to 5% of its issued shares while reaffirming FY27 cash NPAT guidance of $16 million or more. The lender also says potential acquisitions could be funded without an equity raising, although no transaction has been announced.

Bellevue Gold delivered record FY26 production and free cash flow while cutting its hedge book by more than half. The next test is whether higher FY27 output and greater spot-price exposure can convert operational progress into materially stronger cash generation.

Korvest has entered FY27 with record work on hand after completing a new 3,500 square metre Kilburn factory, even as FY26 profit and operating cash flow declined. The ASX-listed manufacturer maintained its 40-cent fully franked final dividend and plans another $4 million capacity investment.